These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Metoprolol as antihypertensive drug. Deleu D; Bohle K Am J Cardiol; 1991 Sep; 68(8):831-2. PubMed ID: 1892107 [No Abstract] [Full Text] [Related]
44. [Systolic pressure--left-ventricular telesystolic volume ratio in the treatment of hypertension with a cardioselective beta-blockader without inner sympathomimetic activity]. Sirakova V Vutr Boles; 1988; 27(3):47-50. PubMed ID: 3206902 [TBL] [Abstract][Full Text] [Related]
45. [Long-term treatment of hypertension with a selective beta-1-blockader without sympathomimetic activity. II. Changes in the structure and function of the left ventricle]. Sirakova V; Penkov N; Kaponov Kh Vutr Boles; 1989; 28(1):31-6. PubMed ID: 2525846 [TBL] [Abstract][Full Text] [Related]
47. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol. Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155 [TBL] [Abstract][Full Text] [Related]
48. The role of the new beta-blockers in treating cardiovascular disease. Weber MA Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195 [TBL] [Abstract][Full Text] [Related]
49. [Long-term treatment of hypertension with a selective beta l-blocker without sympathomimetic activity. I. Antihypertensive and hemodynamic effects]. Sirakova V; Penkov N; Kaponov Kh Vutr Boles; 1988; 27(6):21-5. PubMed ID: 3073572 [TBL] [Abstract][Full Text] [Related]